doi: 10.1016/j.joca.2024.02.003 9
At a Glance What changed in April On 15 April 2026 the FDA updated its Section 503A bulk drug substances list, removing 12 peptides from Category 2 the designation the agency uses for substances it considers to raise significant safety concerns for compounding
In one preferred practice of the invention, one or more S-acyl glutathione derivatives is applied in admixture with the dermatologically acceptable carrier or vehicle (e.g., as a lotion, cream, ointment, soap, stick, or the like) so as to facilitate topical application and, in some cases, provide additional therapeutic effects as might be brought about, e.g., by moisturizing of the affected skin areas
Research published in the Journal of Cosmetic Dermatology suggests that adequate B12 levels support the skin's natural barrier function and may help prevent premature aging
CONTAINS PHOSPHOLIPIDS DERIVED FROM SOY LECITHIN
Through a randomized, double-blind, placebo-controlled trial involving 20 pediatric T1D patients, Reddi et al